Rosuvastatin Calcium/Ezetimibe Tablet 10/10 mg

Adult dose

This drug is administered once daily without regard to meals. For primary hypercholesterolemia, it starts at 10/5 mg per day and can be increased up to 10/20 mg as needed. The lipid levels in the blood should be checked at intervals of 4 weeks or more following initiation of treatment or dose adjustments to adjust the dosage. Patients taking Ezetimibe and Rosuvastatin together may switch to a combination product with the same active ingredient content for convenience.

This drug may carry a risk of muscle abnormalities, so immediate medical attention should be sought if serious muscle pain or weakness occurs. In particular, if severe infections, hypotension, major surgery or trauma, or hypothyroidism are present, the use of this drug may need to be temporarily stopped or discontinued. Patients with allergies to any components of this drug, severely impaired liver or kidney function, pregnant women, or nursing women should not use this drug. Additionally, caution is required if there is a history of muscle disease or if this drug is used in conjunction with certain medications. Liver function and muscle status should be regularly monitored during treatment, and if there are significant increases in liver enzyme levels or worsening of muscle-related abnormal symptoms, dosing should be discontinued. Patients with a history of alcohol abuse or liver disease, the elderly, and those taking certain medications should use this drug carefully. This drug can rarely cause serious skin reactions or severe muscle weakness, so medical consultation should be sought immediately if skin rashes or muscle weakness occur. Pregnant or nursing women should not use this drug, and women of childbearing age should ensure effective contraception during treatment. Safety in children and adolescents has not been sufficiently confirmed, so it is not recommended. This drug may interact with other medications, so it is essential to inform your doctor or pharmacist of any other medications being taken. In cases of overdose, as there is no specific antidote, appropriate treatment and monitoring based on symptoms are necessary. This drug should be kept out of the reach of children and should not be transferred to other containers.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in the mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory issues along with cough and fever, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, urination issues

Mild side effects

• Pharyngitis
• dyspepsia
• headache
• dizziness
• constipation
• nausea
• abdominal pain
• dry mouth
• elevated liver enzymes
• abnormal liver function tests

This drug may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance

Yellow oblong film-coated tablet

Package unit

30 tablets (10 tablets/PTP × 3), 100 tablets/bottle